sb 203580 has been researched along with Infection, Mycobacterium avium-intracellulare in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kroon, FP; Kumararatne, DS; Kurimoto, M; Lammas, DA; Ottenhoff, TH; Sanal, O; Sinigaglia, F; Smits, HH; Verhagen, CE; Verreck, FA; Wierenga, EA | 1 |
1 other study(ies) available for sb 203580 and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.
Topics: Adolescent; Adult; Antigens, CD; Butadienes; Child; Child, Preschool; DNA-Binding Proteins; Enzyme Inhibitors; Female; Humans; Imidazoles; Infant; Integrin alpha6; Interferon-alpha; Interferon-gamma; Interleukin-12; Interleukin-18; Interleukin-18 Receptor alpha Subunit; Interleukin-4; Male; Mycobacterium avium-intracellulare Infection; Nitriles; Proto-Oncogene Proteins c-myc; Pyridines; Receptor, Interferon alpha-beta; Receptors, Interferon; Receptors, Interleukin; Receptors, Interleukin-12; Receptors, Interleukin-18; Salmonella Infections; Signal Transduction; STAT4 Transcription Factor; T-Lymphocytes; Th1 Cells; Trans-Activators | 2000 |